Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michel Goldman

Showing results (11-20 of 188) with videos related to

Pageof 19
Sort By:
Biotechnology Journal|September 2, 2014
Editorial: The Innovative Medicines Initiative--collaborations are key to innovating R&D processesHugh Laverty, Michel Goldman
Plos Medicine|May 24, 2021
Thrombotic thrombocytopenia associated with COVID-19 infection or vaccination: Possible paths to platelet factor 4 autoimmunityMichel Goldman, Cédric Hermans
The New England Journal of Medicine|August 23, 2018
Free Drug Samples and the Opioid CrisisMathias Dewatripont, Michel Goldman
Scientific American|September 29, 2009
Boosting vaccine powerNathalie Garçon, Michel Goldman
Transplant International : Official Journal of the European Society for Organ Transplantation|September 7, 2007
European research on cell and organ transplantation: towards novel opportunities?Michel Goldman, Kathryn Wood
The New England Journal of Medicine|June 5, 2014
Fostering responsible data sharing through standardsRebecca Kush, Michel Goldman
Frontiers in Medicine|October 12, 2020
Reflections on the Collaborative Fight Against COVID-19Michel Goldman, Mitchell Silva
Future Medicinal Chemistry|March 22, 2014
The innovative medicines initiative: a case study for new ways of working in drug R&DHugh Laverty, Michel Goldman
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|February 27, 2003
Non-classical pathways of cell-mediated allograft rejection: new challenges for tolerance induction?Alain Le Moine, Michel Goldman
Nature|August 27, 2010
Clarifying knowledge ownership in Europe's medicines initiativeKim De Rijck, Michel Goldman
Pageof 19

Showing results (11-20 of 188) with videos related to

Sort By:
Pageof 19
Biotechnology Journal|September 2, 2014
Editorial: The Innovative Medicines Initiative--collaborations are key to innovating R&D processesHugh Laverty, Michel Goldman
Plos Medicine|May 24, 2021
Thrombotic thrombocytopenia associated with COVID-19 infection or vaccination: Possible paths to platelet factor 4 autoimmunityMichel Goldman, Cédric Hermans
The New England Journal of Medicine|August 23, 2018
Free Drug Samples and the Opioid CrisisMathias Dewatripont, Michel Goldman
Scientific American|September 29, 2009
Boosting vaccine powerNathalie Garçon, Michel Goldman
Transplant International : Official Journal of the European Society for Organ Transplantation|September 7, 2007
European research on cell and organ transplantation: towards novel opportunities?Michel Goldman, Kathryn Wood
The New England Journal of Medicine|June 5, 2014
Fostering responsible data sharing through standardsRebecca Kush, Michel Goldman
Frontiers in Medicine|October 12, 2020
Reflections on the Collaborative Fight Against COVID-19Michel Goldman, Mitchell Silva
Future Medicinal Chemistry|March 22, 2014
The innovative medicines initiative: a case study for new ways of working in drug R&DHugh Laverty, Michel Goldman
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|February 27, 2003
Non-classical pathways of cell-mediated allograft rejection: new challenges for tolerance induction?Alain Le Moine, Michel Goldman
Nature|August 27, 2010
Clarifying knowledge ownership in Europe's medicines initiativeKim De Rijck, Michel Goldman
Pageof 19